Gastric Cancer Models Developed via GelMA 3D Bioprinting Accurately Mimic Cancer Hallmarks, Tumor Microenvironment Features, and Drug Responses
Small · 2025-02 · 21 (8)
DOI: 10.1002/smll.202409321 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 15.01.2025. Verfasst von Mingguang Ju und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology and General Surgery Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Educa…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Bioprinting, Tumor Microenvironment, Printing, Three-Dimensional. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Key Research and Development Program of Liaoning Province, National Key Laboratory Foundation of China.
Abstract (Originalsprache)
Current in vitro models for gastric cancer research, such as 2D cell cultures and organoid systems, often fail to replicate the complex extracellular matrix (ECM) found in vivo. For the first time, this study utilizes a gelatin methacryloyl (GelMA) hydrogel, a biomimetic ECM‐like material, in 3D bioprinting to construct a physiologically relevant gastric cancer model. GelMA's tunable mechanical properties allow for the precise manipulation of cellular behavior within physiological ranges. Genetic and phenotypic analyses indicate that the 3D bioprinted GelMA (3Db) model accurately mimics the clinical tumor characteristics and reproduces key cancer hallmarks, such as cell proliferation, invasion, migration, angiogenesis, and the Warburg effect. Comparisons of gene expression and drug responses between the 3Db model and patient‐derived xenograft models, both constructed from primary gastric cancer cells, validate the model's clinical relevance. The ability of the 3Db model to closely simulate in vivo conditions highlights its crucial role in identifying treatment targets and predicting patient‐specific responses, showcasing its potential in high‐throughput drug screening and clinical applications. This study is the first to report the pivotal role of GelMA‐based 3D bioprinting in advancing gastric cancer research and regenerative medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Oncology and General Surgery Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education The First Affiliated Hospital of China Medical University, Shenya…
- Department of Neurosurgery, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China.
- Institute of Metal Research, Chinese Academy of Sciences, Shenyang, 110016, China.
- Department of Cell Biology, Key Laboratory of Cell Biology, National Health Commission of the PRC and Key Laboratory of Medical Cell Biology, Ministry of Education of the PRC, China Medical University, Shenyang, 110122,…
ORCID-Profile: Mingguang Ju, Kai Li
Förderung
- Key Research and Development Program of Liaoning Province
- National Key Laboratory Foundation of China
Zitieren
APA
Ju, M., Jin, Z., Yu, X., Huang, C., Li, Y., Gao, Z., Li, H., Huang, H., Zheng, C., Jia, S., Zhang, Y., Liu, X., Zhou, H., Zhang, X., & Li, K. (2025). Gastric Cancer Models Developed via GelMA 3D Bioprinting Accurately Mimic Cancer Hallmarks, Tumor Microenvironment Features, and Drug Responses. Small, 21(8). https://doi.org/10.1002/smll.202409321
Vancouver
Ju M, Jin Z, Yu X, Huang C, Li Y, Gao Z, et al. Gastric Cancer Models Developed via GelMA 3D Bioprinting Accurately Mimic Cancer Hallmarks, Tumor Microenvironment Features, and Drug Responses. Small. 2025;21(8). doi:10.1002/smll.202409321
BibTeX
@article{Ju2025,
author = {Ju, Mingguang and Jin, Zhizhong and Yu, Xue and Huang, Caihao and Li, Yanshu and Gao, Ziming and Li, He and Huang, Haibo and Zheng, Chen and Jia, Shiheng and Zhang, Yixiao and Liu, Xiaofang and Zhou, Heng and Zhang, Xing and Li, Kai},
title = {Gastric Cancer Models Developed via GelMA 3D Bioprinting Accurately Mimic Cancer Hallmarks, Tumor Microenvironment Features, and Drug Responses},
journal = {Small},
year = {2025},
volume = {21},
number = {8},
doi = {10.1002/smll.202409321}
}
EUVIMED